revefenacin Inhalation solution 175 mcg/3 ml
Dossier type
US CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
FDA
Unavailable markets
United States
Comments
REFERENCE PRODUCT: Yupelri® Mylan. Filed: US
Manufacturer #8822
A pharmaceutical manufacturer based in Europe that has been active in 60+ countries selling its products in Europe, North America, LATAM, MENA, and Asia for 50+ years.
The main therapeutic areas include CNS, ophthalmology, and dermatology.
Main dosage forms include sterile and solid oral dosage forms.
The company's production lines are cGMP-compliant.
The company possesses branches in Europe, North America, and Asia.
Manufacturer usually replies in 31 days